Effect of the apolipoprotein C-II/C-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles

Atherosclerosis

Volumn 127, Issue 2, 1996, Pages 205-212

  Lambert, Daniel A ^a   Catapano, Alberico L ^b   Smith, Louis C ^b   Sparrow, John T ^b   Gotto Jr , Antonio M ^b  

^a INSERM   (France)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

apolipoproteins; lipoprotein lipase; protein cofactors

Indexed keywords

APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; CHOLESTEROL; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYDROLYSIS; LIPID METABOLISM; PRIORITY JOURNAL;

EID: 0030595992     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05955-2     Document Type: Article

References (60)

1. [1] Havel RJ, Fielding CJ, Olivecrona T, Shore VG, Fielding RE, Egelrud T. Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoprotein lipase from different sources. Biochemistry 1973;12:1828-1833.
2. [2] LaRosa JC, Levy RI, Herbert PN, Lux SE, Fredrickson D. A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Comm 1970;41:57-62.
3. [3] Fitzharris TJ, Quinn DM, Goh EH et al. Hydrolysis of guinea pig nascent very low density lipoproteins catalyzed by lipoprotein lipase: activation by human apolipoprotein CII. J Lipid Research 1981;22:921-933.
4. [4] Vaino P, Virtanen JA, Kinnunen RKJ et al. Action of lipoprotein lipase on phospholipids monolayers. Activation by apolipoprotein CII. Am Chem Soc 1983;22:2270-2275.
5. [5] Krauss RM, Herbeth RN, Levy RI, Fredrickson DS. Further observations of the activation and inhibition of lipoprotein lipase by apolipoproteins. Circ Res 1973;33:403-411.
6. [6] Carlson LA, Ballantyne D. Changing relative proportions of apolipoproteins C II and C III of very low density lipoproteins in hypertriglyceridemia. Atherosclerosis 1976;23:563-568.
7. [7] Lambert D, Max JP, Mejean L, Pointel JP, Drouin P, Debry G. Correlations between the apoprotein C composition of very low density lipoproteins and triglyceridemia in subjects with type IV hyperlipoproteinemia. J Lab Clin Med 1981;97:834-841.
8. [8] Carlson LA, Wahlberg G. Relative increase in apolipoprotein CII content of VLDL and chylomicrons in a case with massive V hyperlipoproteinemia by nicotinic acid treatment. Atherosclerosis 1978;31-77.
9. [9] Lambert D, Max JP, Méjean L, Pointel JR, Drouln R, Debry G. Modifications in apoprotein C composition of the very low density lipoproteins in type IV hyperlipoproteinemic subjects after dietetic triglyceridemia reduction, Ann Biol Clin 1983;41:251-254.
10. [10] Smith LC, Voyta JC, Catapano AL, Kinnunen PKJ, Gotto AM Jr, Sparrow JT. Activation of lipoprotein lipase by synthetic fragments of apolipoprotein C-II. Ann NY Acad Sci 1980;348:213-223.
11. [11] Egelrud T, Olivecrona T. Purified bovine milk lipoprotein lipase: activity against lipid substrates in the absence of exogenous serum factors. Biochem Biophys Acta 1973;306:115-127.
12. [12] Kinnunen PKJ, Huttunen JK, Ehnholm C. Properties of purified bovine milk lipoprotein lipase. Biochim Biophys Acta 1976;450:342-351.
13. [13] Catapano AL, Kinnunen PKJ, Breckenridge WC et al. Lipolysis of apo C-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apo C-II. Biochem Biophys Res Commun 1979;89:951-957.
14. [14] Breckenridge CW, Utile JA, Steiner G, Chow A, Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein CII. N Eng J Med 1978;298:1265-1273.
15. [15] Smith LC, Voyta JC, Paavo KJ, Kinnunen PKJ, Gotto AM Jr, Sparrow JT. Lipoprotein lipase interaction with synthetic N-dansyl fragments of apolipoprotein C-II. Biophys J 1982;174-175.
16. [16] Chung J, Scanu AM. Isolation, molecular properties, and kinetic characterization of lipoprotein lipase from rat heart. J Biol Chem 1977;252:4202-4209.
17. [17] Miller AL, Smith LC. Activation of lipoprotein lipase by apolipoprotein glutamic acid. J Biol Chem 1973;248:3359-3362.
18. [18] Kinnunen PKJ, Jackson RL, Smith LC, Gotto AM Jr, Sparrow JT. Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. Proc Natl Acad Sci USA 1977;74:4848-4851.
19. [19] Fojo SS, Brewer HB. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J Int Med 1992;231:669-677.
20. [20] Fojo SS, Brewer HB Jr. The familial hyperchylomicronemia syndrome. J Am Med Assoc 1991;265:904-908.
21. [21] Auwerx JH, Babirak SP, Fujimoto WY, Iverius PH, Brunzell JD. Defective enzyme protein in lipoprotein lipase deficiency. Eur J Clin invest 1986;19:433-447.
22. 51 Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease. J Clin Invest 1987;80:1597-1606.
23. Nigmegen) of a patient with a deficiency of apolipoprotein C-II. J Biol Chem 1988;263:17913-17916.
24. Bari). Biochem Biophys Res Commun 1990;168:1118-1127.
25. [25] Reina M, Brundel JD, Deeb SS. Molecular basis of familial chylomicronemia: mutation in the lipoprotein lipase and apolipoprotein C-II genes. J Lipid Res 1992;33:1823-1832.
26. Tpronto, a non-functional human apolipoprotein. Proc Natl Acad Sci USA 1987;84:270-273.
27. [27] Kirchgessner TG, Chuat JC, Heinzmann C et al. Organisation of the human lipoprotein lipase gene and evolution of the lipase gene family. Proc Natl Acad Sci USA 1989;86:94647-94651.
28. [28] Kashyap ML, Srivastava LS, Hynd BA et al. Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome. Atherosclerosis 1980;35:29-40.
29. [29] Fielding CJ, Fielding PE. Chylomicrons protein content and the rate of lipoprotein lipase activity. J Lipid Res 1976;17:419-423.
30. [30] Ekman R, Nilsson-Ehle P. Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue. Clin Acta 1976;63:29-35.
31. [31] Brown WV, Levy RI, Fredrickson DS. Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem 1969;244:5687-5694.
32. [32] McConathy WJ, McCaffree MA, Lane DM, Polymorphism of human plasma apolipoprotein C-III at birth and in early neonatal life. J Lipid Res 1987;28:1193-1198.
33. [33] Chariton SC, Olson JS, Hong KY, Pownall HJ, Louie DD, Smith LC. Stopped flow kinetics of pyrene transfer between human high density lipoproteins. J Biol Chem 1976;251:7952-7955.
34. [34] Chariton SC, Hong KY, Smith LC. Kinetics of rac-1-oleyl-2-4-(3-pyrenyl) butanoylglycerol transfer between high density lipoproteins. Biochemistry 1978;17:3304-3309.
35. [35] Almgren M. Migration and partitioning of pyrene and perytene between lipid vesicles in aqueous solution studied with a fluorescence Stopped-Flow technique. J Am Chem Soc 1980;102:7882-7887.
36. [36] Massey JB, Gotto AM Jr, Pownall HJ. Kinetics and mechanism of the spontaneous transfer of fluorescent phosphatidylcholines between apolipoproteins phospholipid recombinants. Biochemistry 1982;21:3630-3636.
37. [37] Massey JB, Gotto AM Jr, Pownall HJ. Kinetics and mechanism of the spontaneous transfer of fluorescent phospholipid between apolipoprotein-phospholipid recombinants. Effect of the polar headgroups. J Biol Chem 1982;257:5444-5448.
38. [38] Doody MC, Pownall HJ, Kao YT, Smith LC. Mechanism and kinetics of transfer of a fluorescent fatty acid between single-walled phosphatidylcholine vesicles. Biochemistry 1980;19:108-116.
39. [39] Batzi S, Korn ED. Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 1973;298:1015-1019.
40. [40] Eisenberg S, Feldman D, Olivecrona T. Effects of two albumins and two detergents on the activity of bovine milk lipoprotein lipase against very low density and high density lipoprotein lipids. Biochim Biophys Acta 1981;665:1454-1462.
41. [41] Chen RF. Removal of fatty acids from serum albumin by charcoal treatment. J Biol Chem 1967;242(2):173-181.
42. [42] Kinnunen PK. Purification of bovine milk lipoprotein lipase with the aid of detergent. Med Biol (Helsinski) 1977;55:187-191.
43. [43] Vainjo R, Virtanen JA, Kinnunen PK, inhibition of lipoprotein lipase by benzene boronic acid. Effect of apolipoprotein C-II. Biochim Biophys Acta 1982;11:386-390.
44. [44] Bohlen R, Stein S, Dairman W, Wendfriend S. Fluorometric assay of proteins in the nanogram range. Arch Biochem Biophys 1973;155:213-220.
45. [45] Jackson RL, Becker HN, Gilliam EB, Gotto AM Jr. Primary structure of very low density-lipoprotein C II of human plasma. Proc Nat Acad Sci USA 1977;74:1942-1945.
46. [46] Herbert RN, Shulman RI, Fredrickson DS. Fractionation of the C-apoproteins from human plasma very low density lipoproteins. J Biol Chem 1973;248:4941-4946.
47. [47] Catapano AL, Jackson RL, Gillian EB, Gotto AM Jr, Smith LC. Quantification of apo C-II and apo C-III of human very low density lipoproteins by analytical isoelectric focusing. J Lipid Res 1978;19:1047-1052.
48. [48] Sparrow JT, Pownall HJ, Hsu FJ, Blumenthal LO, Culwell AR, Gotto AM Jr. Lipid binding by fragments of apolipoprotein C-III-I obtained by thrombin cleavage. Biochemistry 1977;16, 25:5427-5431.
49. [49] Stocks J, Holdsworth G, Dodson P, Galton DJ. Post translational defect of apolipoprotein C III in hypertriglyceride-rich lipoproteins of patients with hypertriglyceridaemia. Medical Research Society; 7-8 Dec. 1979; Guy's Hospital, London (England). Clin Sci 1979;58:17P.
50. 0 lacks carbohydrate residues: use of mass spectrometry to study apolipoprotein structure. J Lipid Res 1989;30, 11:1781-1787.
51. [51] Sparrow JT, Gotto AM Jr. Phospholipid binding studies with synthetic apolipoprotein fragments. Ann NY Acad Sci 1980;348:187-211.
52. [52] McConathy WJ, Gesquiere JC, Bass H, Tartar A, Fruchart J-C, Wang C-S. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein CIII. J Lipid Res 1992;33:995-1003.
53. [53] Fredrickson DS, Lavy RD. Familial hyperlipoproteinemias. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds). The Metabolic Basis of Inherited Disease, 3th edn, New York: McGraw-Hill, 1972, pp. 545-614.
54. [54] Faton RR, Kipnis DM. Effects of glucose feeding on lipoprotein synthesis in the rat. Am J Physiol 1969;217:1153-1159.
55. [55] Nestel PJ, Hirsch EZ. Mechanism of alcohol-induced hyprtriglyceridemia. J Lab Clin Med 1965;66:357-365.
56. [56] Baraona E, Lieber CS. Effects of chronic ethanol feeding on serum lipoprotein metabolism in the rat. J Clin Invest 1970;49:769-778.
57. [57] Boberg J. Heparin-released blood plasma lipoprotein lipase activity in patients with hyperlipoproteinemia. Acta Med Scand 1973;191:97-102.
58. [58] Huttunen JK, Ehnholm C, Kekki M, Nikkilä EA. Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin Sci Mol Med 1976;50:249-260.
59. [59] Persson B. Lipoprotein lipase activity of human adipose tissue in different types of hyperlipidemia. Acta Med Scand 1973;193:447-456.
60. [60] Nishizawa Y, Shoji T, Nishitani H, Yamakawa M, Konishi T, Kawasaki K, Morii H. Hypertriglyceridemia and lowered apolipoprotein CII/CIII ratio in uremia: effect of a fibric acid, clinofibrate. Kidney Int 1993;44(6):1352-1359.